This panel will bring together four distinguished experts to unpack how ADHD diagnosis and treatment are shaped by systemic inequities — particularly culture, race, socioeconomic status, and access to care. While ADHD is often framed purely as a neurobiological disorder, the reality is that disparities in diagnosis and treatment perpetuate inequities, disproportionately affecting under-served and under-diagnosed communities. Over the course of the hour, panelists will explore how stigma, gender, health care infrastructure, school systems, and broader social determinants influence who gets diagnosed, how early, and whether they receive effective support.
Audience participants will leave with a nuanced understanding of:
-The structural and cultural barriers to ADHD recognition
-How race, class, gender and systemic bias influence clinical assessment
-The impact of unequal access to evidence-based treatment (behavioral, pharmacological, educational)
-Strategies for more equitable advocacy, policy, and intervention
